Phase I study of nanoparticle albumin-bound paclitaxel, carboplatin and trastuzumab in women with human epidermal growth factor receptor 2-overexpressing breast cancer.
Tezuka K, Takashima T, Kashiwagi S, Kawajiri H, Tokunaga S, Tei S, Nishimura S, Yamagata S, Noda S, Nishimori T, Mizuyama Y, Sunami T, Ikeda K, Ogawa Y, Onoda N, Ishikawa T, Kudoh S, Takada M, Hirakawa K.
Tezuka K, et al. Among authors: onoda n.
Mol Clin Oncol. 2017 Apr;6(4):534-538. doi: 10.3892/mco.2017.1176. Epub 2017 Feb 24.
Mol Clin Oncol. 2017.
PMID: 28413662
Free PMC article.